|
|
Volumn 10, Issue 4, 2014, Pages 181-
|
|
Chronic kidney disease: Empagliflozin-one step closer to glycaemic control in patients with type II diabetes and CKD
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
CREATININE;
EMPAGLIFLOZIN;
GLUCOSE;
HEMOGLOBIN A1C;
ANTIDIABETIC AGENT;
BENZHYDRYL DERIVATIVE;
GLUCOSIDE;
CHRONIC KIDNEY DISEASE;
CREATININE URINE LEVEL;
DIASTOLIC BLOOD PRESSURE;
DRUG EFFICACY;
DRUG TOLERABILITY;
GLOMERULUS FILTRATION RATE;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
KIDNEY FUNCTION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SYSTOLIC BLOOD PRESSURE;
WEIGHT REDUCTION;
DIABETES MELLITUS, TYPE 2;
FEMALE;
MALE;
RENAL INSUFFICIENCY, CHRONIC;
BENZHYDRYL COMPOUNDS;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLUCOSIDES;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
RENAL INSUFFICIENCY, CHRONIC;
|
|
EID: 84897114463
PISSN: 17595061
EISSN: 1759507X
Source Type: Journal
DOI: 10.1038/nrneph.2014.20 Document Type: Note |
|
Times cited : (2)
|
|
References (2)
|
